Fig. 3.
Per cent change from baseline in UACR in the overall population (a) and in participants with normoalbuminuria (b), microalbuminuria (c) or macroalbuminuria (d) at baseline (all FAS). The numbers by each time point are the placebo-adjusted difference, reported as % (95% CI). The number for treatment groups at each time point was the number of participants on study medication or who discontinued study medication ≤2 days before the sample was collected